MedTrace Logo

Acceptability and Tolerance Study of an Amino Acid Formula with HMOs

NCT04575298 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2024-10-15

No results posted yet for this study

Summary

To evaluate the acceptability (including gastrointestinal tolerance and compliance) of a hypoallergenic amino acid infant formula with HMOs for the dietary management of cows' milk allergy in infants less than 12 months of age.

Conditions

  • Infant Development

Interventions

DIETARY_SUPPLEMENT

Acceptability, tolerance study for an infant formula with human milk oligosaccharides

Prospective study

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Konstantinos Kakleas · Paediatric allergy consultant

Eligibility

Min Age
1 Month
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-12
Primary Completion
2020-12-22
Completion
2020-12-22

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04575298 on ClinicalTrials.gov